The Desire Drug That Had to Pass a Safety Gate
Approval was not a celebration. It was a negotiation. Most drug launches are presented as clean victories: a new treatment, a new option, a new market. Flibanserin was different. Before it became known to the public as “Female Viagra,” it had already become a regulatory argument. The FDA approval process was not only about whether the drug could increase sexual desire. It was about...
0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр